| 000 | 01570 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513153529.0 | ||
| 264 | 0 | _c19990107 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0888-0018 | ||
| 024 | 7 |
_a10.3109/08880019809016571 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamada, Y | |
| 245 | 0 | 0 |
_aAtaxia telangiectasia associated with B-cell lymphoma: the effect of a half-dose of the drugs administered according to the acute lymphoblastic leukemia standard risk protocol. _h[electronic resource] |
| 260 |
_bPediatric hematology and oncology _c |
||
| 300 |
_a425-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAtaxia Telangiectasia _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGenes, Recessive |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aInoue, R | |
| 700 | 1 | _aFukao, T | |
| 700 | 1 | _aKaneko, H | |
| 700 | 1 | _aIsogai, K | |
| 700 | 1 | _aFukuda, S | |
| 700 | 1 | _aShimozawa, N | |
| 700 | 1 | _aSuzuki, Y | |
| 700 | 1 | _aKondo, N | |
| 700 | 1 | _aAzuma, E | |
| 700 | 1 | _aSakurai, M | |
| 773 | 0 |
_tPediatric hematology and oncology _gvol. 15 _gno. 5 _gp. 425-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/08880019809016571 _zAvailable from publisher's website |
| 999 |
_c9747860 _d9747860 |
||